RELATING TO ACCESS TO TREATMENT FOR TERMINALLY ILL PATIENTS.

Beginning on January 1, 2025, permits manufacturers of investigational drugs or biological products to make these drugs and products available to terminally ill patients under certain conditions.

Voted 1/24/2024

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

Docket history

Action history

1/24/2024Referred to HLT, CPC, referral sheet 2
1/22/2024Introduced and Pass First Reading.
1/19/2024Pending introduction.